Literature DB >> 22286564

Prediction of conversion to psychosis: review and future directions.

Dylan G Gee1, Tyrone D Cannon.   

Abstract

This article reviews recent findings on predictors of conversion to psychosis among youth deemed at ultra high risk (UHR) based on the presence of subpsychotic-intensity symptoms or genetic risk for psychosis and a recent decline in functioning. Although transition rates differ between studies, the most well powered studies have observed rates of conversion to full psychosis in the 30-40% range over 2-3 years of follow-up. Across studies, severity of subthreshold positive symptoms, poorer social functioning, and genetic risk for schizophrenia appear to be consistent predictors of conversion to psychosis, with algorithms combining these indicators achieving positive predictive power > 80%. Nevertheless, a substantial fraction of UHR cases do not convert to psychosis. Recent work indicates that UHR cases who present with lower levels of negative symptoms and higher levels of social functioning are more likely to recover symptomatically and no longer meet criteria for an at-risk mental state. In general, it appears that about 1/3 of UHR cases convert to psychosis, about 1/3 do not convert but remain symptomatic and functionally impaired, and about 1/3 recover symptomatically and functionally. Continued efforts to detect early risk for psychosis are critical for informing early intervention and provide increasing promise of delaying or even preventing the onset of psychosis.

Entities:  

Mesh:

Year:  2011        PMID: 22286564      PMCID: PMC4098037          DOI: 10.1590/s1516-44462011000600002

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  15 in total

1.  The schizophrenia prodrome revisited: a neurodevelopmental perspective.

Authors:  Barbara A Cornblatt; Todd Lencz; Christopher W Smith; Christoph U Correll; Andrea M Auther; Emilie Nakayama
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

Review 2.  Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research.

Authors:  Nasra Haroun; Laura Dunn; Ansar Haroun; Kristin S Cadenhead
Journal:  Schizophr Bull       Date:  2005-10-05       Impact factor: 9.306

Review 3.  Prospective investigations of the prodromal state of schizophrenia: review of studies.

Authors:  K A Olsen; B Rosenbaum
Journal:  Acta Psychiatr Scand       Date:  2006-04       Impact factor: 6.392

4.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna Lifshey Rosen; Lubna Somjee; Philip J Markovich; Kelly Stein; Scott W Woods
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

5.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

6.  Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up.

Authors:  Alison R Yung; Barnaby Nelson; Carrie Stanford; Magenta B Simmons; Elizabeth M Cosgrave; Eoin Killackey; Lisa J Phillips; Andreas Bechdolf; Joe Buckby; Patrick D McGorry
Journal:  Schizophr Res       Date:  2008-09-02       Impact factor: 4.939

7.  Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial.

Authors:  Anthony P Morrison; Paul French; Lara Walford; Shôn W Lewis; Aoiffe Kilcommons; Joanne Green; Sophie Parker; Richard P Bentall
Journal:  Br J Psychiatry       Date:  2004-10       Impact factor: 9.319

8.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01

9.  Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.

Authors:  Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Shona M Francey; Colleen A McFarlane; Mats Hallgren; Patrick D McGorry
Journal:  Schizophr Res       Date:  2003-03-01       Impact factor: 4.939

10.  Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.

Authors:  Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Patrick D McGorry
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

View more
  14 in total

Review 1.  Attenuated psychosis syndrome in DSM-5.

Authors:  Ming T Tsuang; Jim Van Os; Rajiv Tandon; Deanna M Barch; Juan Bustillo; Wolfgang Gaebel; Raquel E Gur; Stephan Heckers; Dolores Malaspina; Michael J Owen; Susan Schultz; William Carpenter
Journal:  Schizophr Res       Date:  2013-06-14       Impact factor: 4.939

2.  Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.

Authors:  Mariana C Diana; Fernanda F Peres; Veronica Justi; Rodrigo A Bressan; Acioly L T Lacerda; José Alexandre Crippa; Jaime E C Hallak; Vanesssa Costhek Abilio
Journal:  CNS Neurosci Ther       Date:  2018-04-14       Impact factor: 5.243

3.  Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.

Authors:  G Brucato; M D Masucci; L Y Arndt; S Ben-David; T Colibazzi; C M Corcoran; A H Crumbley; F M Crump; K E Gill; D Kimhy; A Lister; S A Schobel; L H Yang; J A Lieberman; R R Girgis
Journal:  Psychol Med       Date:  2017-03-02       Impact factor: 7.723

4.  Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.

Authors:  Heidi W Thermenos; Richard J Juelich; Samantha R DiChiara; Raquelle I Mesholam-Gately; Kristen A Woodberry; Joanne Wojcik; Nikos Makris; Matcheri S Keshavan; Susan Whitfield-Gabrieli; Tsung-Ung W Woo; Tracey L Petryshen; Jill M Goldstein; Martha E Shenton; Robert W McCarley; Larry J Seidman
Journal:  Schizophr Res       Date:  2016-03-07       Impact factor: 4.939

5.  Auditory event-related potentials and α oscillations in the psychosis prodrome: neuronal generator patterns during a novelty oddball task.

Authors:  Jürgen Kayser; Craig E Tenke; Christopher J Kroppmann; Daniel M Alschuler; Shiva Fekri; Shelly Ben-David; Cheryl M Corcoran; Gerard E Bruder
Journal:  Int J Psychophysiol       Date:  2013-12-13       Impact factor: 2.997

6.  Olfaction in the psychosis prodrome: electrophysiological and behavioral measures of odor detection.

Authors:  Jürgen Kayser; Craig E Tenke; Christopher J Kroppmann; Daniel M Alschuler; Shelly Ben-David; Shiva Fekri; Gerard E Bruder; Cheryl M Corcoran
Journal:  Int J Psychophysiol       Date:  2013-07-13       Impact factor: 2.997

7.  Antipsychotic prescription, assumption and conversion to psychosis: resolving missing clinical links to optimize prevention through precision.

Authors:  TianHong Zhang; Andrea Raballo; JiaHui Zeng; RanPiao Gan; GuiSen Wu; YanYan Wei; LiHua Xu; XiaoChen Tang; YeGang Hu; YingYing Tang; HaiChun Liu; Tao Chen; ChunBo Li; JiJun Wang
Journal:  Schizophrenia (Heidelb)       Date:  2022-05-04

8.  Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis.

Authors:  Lisa Buchy; Diana Perkins; Scott W Woods; Lu Liu; Jean Addington
Journal:  Schizophr Res       Date:  2014-05-14       Impact factor: 4.939

9.  Social Cognition in Individuals at Ultra-High Risk for Psychosis: A Meta-Analysis.

Authors:  R J M van Donkersgoed; L Wunderink; R Nieboer; A Aleman; G H M Pijnenborg
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

10.  "To see or not to see: that is the question." The "Protection-Against-Schizophrenia" (PaSZ) model: evidence from congenital blindness and visuo-cognitive aberrations.

Authors:  Steffen Landgraf; Michael Osterheider
Journal:  Front Psychol       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.